Uzbekistan To Implement Large Pharma Projects

 
• By Mainbayar Badarch

Uzbekistan is the most populous country in Central Asia with 36 million people. The country has the only plant in Central Asia specializing in insulin production for the treatment of diabetes. Uzbek authorities aim to develop 90 pharma projects worth $1.2bn by 2026.  

Uzbekistan map
• Source: Shutterstock

More from Business Strategy

More from In Vivo